Matrix metalloproteinase 9 activity in patients before and after endovascular or surgical repair of abdominal aortic aneurysms

Vascular

Volumn 12, Issue 5, 2004, Pages 312-317

  Taurino, Maurizio ^a   Visco, Vincenzo ^a   Raffa, Salvatore ^a   Ricci, Benedetto ^a   Ruggiero, Massimo ^a   Torrisi, Maria Rosaria ^a   Fiorani, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Abdominal aortic aneurysm; Endovascular repair; Matrix metalloproteinase 9

Indexed keywords

GELATINASE B;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM SURGERY; AORTA SURGERY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOVASCULAR SURGERY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME RELEASE; FEMALE; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SMOKING; SURGICAL PATIENT;

EID: 10644263107     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1258/rsmvasc.12.5.312     Document Type: Article

References (36)

1. Scott RA, Ashton HA, Kay DN. Abdominal aortic aneurysm in 4237 screened patients: prevalence, development and management over 6 years. Br J Surg 1991;78:1122-5.
2. Alcorn HG, Wolfson SK Jr, Sutton-Tyrrel K, et al. Risk factors for abdominal aneurysms in older adults enrolled in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1996;16:963-70.
3. Office of Population Censuses and Surveys. Mortality statistics cause series DII2, n.18. 1991;2:297.
4. Gloviczki P, Pairolero PC, Mucha P Jr, et al. Ruptured abdominal aortic aneurysms: repair should not be denied. J Vasc Surg 1992;15:851-9.
5. Noel AA, Gloviczki P, Cherry KJ, et al. Ruptured abdominal aortic aneurysms: the excessive mortality rate of conventional repair. J Vasc Surg 2001;34:41-6.
6. Lee WA, Carter JW, Upchurch G, et al. Perioperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms in the United States during 2001. J Vasc Surg 2004;39:491-6.
7. Harris PL, Rao Vallabhaneni S, Desgranges P, et al, for the EUROSTAR Collaborators. Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. J Vasc Surg 2000;32:739-49.
8. Newman KM, Jean-Claude J, Li H, et al. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 1994;20:814-20.
9. Fontaine V, Jacob MP, Houard X, et al. Involvment of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 2002;161:1701-10.
10. Lemaitre V, Soloway PD, D'Armiento J. Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1. Circulation 2003;107:333-8.
11. Silence J, Collen D, Lijnen HR. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1). Circ Res 2002;90:897-903.
12. McMillan WD, Pearce WH. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 1999;29:122-9.
13. Hovsepian DM, Zipurin SJ, Sakurai MK, et al. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 2000;11:1345-52.
14. McMillan WD, Tamarina NA, Cipollone M, et al. The relationship between MMP-9 expression and aortic diameter. Circulation 1997;96:2228-32.
15. Baxter BT, Davis VA, Minion DJ, et al. Abdominal aortic aneurysms are associated with altered matrix proteins of the non-aneurysmal aortic segments. J Vasc Surg 1994;19:797-803.
16. Annabi B, Shédid D, Ghosn P, et al. Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. J Vasc Surg 2002;35:539-46.
17. Brown SL, Backstrom B, Busuttil RW. A new serum proteolytic enzyme in aneurysm pathogenesis. J Vasc Surg 1985;2:393-9.
18. Sangiorgi G, D'Averio R, Mauriello A, et al. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 2001;104(12 Suppl 1):I288-95.
19. Lorelli DR, Jean-Claude JM, Fox G, et al. Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implication for endoleak. J Vasc Surg 2002;35:916-2.
20. Loftus IM, Naylor AR, Bell PR, Thompson MM. Plasma MMP-9 - a marker of carotid instability. Eur J Vasc Endovasc Surg 2001;21:17-21.
21. Swanson RJ, Littooy FN, Hunt TK, Stoney RJ. Laparotomy as precipitating factor in the rupture of intra-abdominal aneurysms. Arch Surg 1980;115:299-30.
22. Durham SJ, Steed DL, Moosa HH, et al. Probability of rupture of an abdominal aortic aneurysm after an unrelated operative procedure: a prospective study. J Vasc Surg 1991;13:248-52.
23. Shteinberg D, Halak M, Shapiro S, et al. Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response. Eur J Vasc Endovasc Surg 2000;20:462-5.
24. Juvonen J, Surcel HM, Satta J, et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1997;17:2843-7.
25. Carmeliet P. Proteinases in cardiovascular aneurysms and rupture: targets for therapy? J Clin Invest 2000;105:1519-20.
26. Lesauskaite V, Tanganelli P, Sassi C, et al. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol 2001;32:1003-11.
27. Petersen E, Gineitis A, Wagberg F, Angquist KA. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture. Eur J Vasc Endovasc Surg 2000;20:457-61.
28. Gilling-Smith G, Brennan J, Harris P, et al. Endotension after endovascular aneurysm repair: definition, classification, and strategies for surveillance and intervention. J Endovasc Surg 1999;6:305-7.
29. Veith FJ, Baum RA, Ohki T, et al. Nature and significance of endoleaks and endotension: summary of opinions expressed at an international conference. J Vasc Surg 2002;35:1029-35.
30. Gilling-Smith GL, Martin J, Sudhindran F, Gould DA. Freedom from endoleak after endovascular aneurysm repair does not equal treatment success. Eur J Vasc Endovasc Surg 2000;19:421-5.
31. Ruengsakulrach P, Sinclair R, Komeda M, et al. Comparative histopathology of radial artery versus internal thoracic artery and risk factors for development of intimal hyperplasia and atherosclerosis. Circulation 1999;100(19 Suppl):II139-44.
32. Poll L, Zanocchi M, Bo M, et al. Risk factors for atherosclerosis: ultrasound evaluation of carotid and femoral arteries in patients examined by coronary angiography. Int Angiol 1993;12:13-20.
33. Silverstein P. Smoking and wound healing. Am J Med 1992;93(1A):22S-4S.
34. Jensen JA, Goodson WH, Hopf HW, Hunt TK. Cigarette smoking decreases tissue oxygen. Arch Surg 1991;126:1131-4.
35. Lind J, Kramhoft M, Bodtker S. The influence of smoking on complications after primary amputations of the lower extremity. Clin Orthop 1991;267:211-7.
36. UK Small Aneurysm Trial Participants. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002;346:1445-52.